WrTH THE INCREASING concern many anaesthetists are feeling toward the rather routine use of halogenated hydrocarbons, we felt it worthwhile to develop a simple technique to avoid these agents in major surgical procedures. The well recognized use of nitrous oxide (N20) plus oxygen (O2), muscle relaxants and hyperventilation provides adequate operating conditions for certain procedures, i.e. chest work, but is somewhat less than adequate for many other operations when, upon reversal of the relaxant, coughing and straining frequently follows which is not to be desired in abdominal or neurosurgical work. This technique can be improved upon by the intermittent injection of thiopentone and meperidine.
Patients were premedicated with any standard dose of narcotic plus atropine to reduce fentanyl induced bradycardia. Anaesthesia induction was commenced with intravenous Innovar (1.0-2.0 mls), immediately followed by the usual sleep dose of thiopentone, succinylcholine, 02 inflation, and endotracheal intubation. Patients were then connected to an Air-Shields "Ventimeter Ventilator" and moderately hyperventilated. A full paralyzing dose of nondepolarizing relaxant was administered and the flow rates of N20 and 02 adjusted to provide approximately 60-70 per cent NzO. Subsequent relaxant doses were governed by the usual clinical signs (wound observation and inflation pressures). Innovar was administered in increments of 0.5--1.0 mls every 35-40 minutes. More frequent Innovar administration was carried out if the usual clinical signs of painful stimuli appeared (sweating, tearing, hypertension, pupil dilation ).
With closure of the peritoneum atropine was administered in a dosage of 1.0 to 1.2 mg intravenously. As the last few skin sutures were placed the pharynx was *Trademark. ~Department of Anaesthesia, Hamilton Civic Hospitals. gently suctioned and neostigmine was given in divided doses (4.0 to 5.0 rag) intravenously. The N20 and ventilator were discontinued at the same time and the endotracheal tube cuff deflated.
Usually as the dressings are being applied the patient will obey commands to open the naouth and the endotraeheal tube can be removed without coughing or straining. If these steps have been carefully and gently carried out the termination of anaesthesia will be most satisfactory. All the patients in this series were responding and had their endotracheal tubes removed before leaving the Operating Room. Table I shows the preponderance of females in the series. This reflects our routine experience in a busy general hospital with a large volume os gynaecological surgery. Table II illustrates that most patients were quite fit as scored by the American Society of Anesthesiologists Classification. Table III shows the usual age spread for general surgery and the oldest patient in the group was 88 years.
I~ESULTS
The site and duration of the operative procedures are shown in Tables IV and   TABLE I SEX NUMBER MALE 37 V. We feel this technique to be of particular benefit in those patients having hepatobiliary and other upper abdominal procedures, where the surgical manipulation alone carries an increased risk of liver damage and post-operative jaundice. Table VI reflects our feeling that part of the safety of this technique is keeping the dosage of depressant drugs low, so that no respiratory depression is carried over into the post-operative phase.
FEMALE 99
The recovery room course of 21 patients showed a bradycardia of 60 beats per minute or less. In seven patients no active treatment was undertaken and in fourteen atropine 0.6 mg was given intravenously. In all these patients we were impressed by the fact that the systolic blood pressure was well maintained, in spite of the slowed heart rate. One patient, having received a total of 2.0 mgm of Innovar pre-operatively, complained of an intensely itchy nose and made purposeless movements of her arms lasting about one hour. There appeared to be no relationship between the site of surgery and the occurrence of bradycardia (9 cases in lower abdominal, 10 in upper abdominal, and 3 in peripheral operative procedures ). Twenty-eight patients presented with what we considered to be relative or absolute contraindieations to the use of a halogenated hydrocarbon anaesthetic agent. These included eleven patients with elinical jaundice or altered liver function tests; fourteen patients who had received a recent halogenated anaesthetic; and three patients who recently had infectious hepatitis or an exposure to infectious hepatitis.
CO~PLICATIONS
There were three post-operative deaths in this series. One patient died ten days following operation with pulmonary embolism and septic shock. One patient on the third post-operative day suddenly was stricken with chest pain of acute coronary artery occlusion and died in heart failure 48 hours later. The third death was a 55-year-old male with known carcinoma of the larynx. He presented for spinal cord decompression following the acute onset of paraplegia. Jaundice and fever developed five days post-operative and at autopsy on the 1Sth post-operative day the liver showed cirrhosis with focal necrosis and metastatic tumour.
Three other patients developed post-operative deep vein thrombosis. One patient made the observation that she felt she knew the operation had started and could "feel" the incision. She experienced no pain and was certainly not distressed by the memory. She was an ill 56-year-old woman undergoing an emergency bowel resection for obstruction. During the ninety minute procedure she received 1.0 ml Innovar initially and 1.0 ml during the operation.
Several areas of the technique are worthy of brief discussion. We felt that at the concentration of N20 we were using (60-70 per cent) there was some doubt that amnesia and analgesia would be sufficient to prevent recall of the surgical experience, ttosen 1 found marked variation in concentration of N20 required to prevent recall of auditory stimuli. Even with 70 per cent N20 some patients would still obey commands. MclntyrC found that with about 70 per cent N20 patients hyperventilated and relaxed had no recall. Hutchison 3 in a large series using a similar technique found a 1.2 per cent incidence of awareness. This author lists the possible causes of awareness during anaesthesia as, (a) inadvertent reduction of N~O in the inspired mixture, (b) patient resistance to N~O, as seen in tolerance to alcohol and other central nervous system depressants, (e) inadequate supplementation of N20, (d) hypoventilation-recognizing the hypnotic effects of a low Paco2, (e) antianalgesie effect of thiopentone.
There also appears to be a good deal of doubt as to whether d-tubocurare exerts a depressant effect on the central nervous system. Cohen 4 and Smith 5 present evidence against central effects, while Hersey 6 presents experimental evidence of respiratory depression independent of myoneural blockade using a cross circulation technique in dogs.
Hyperventilation would appear to be useful in this technique as the analgesia produced is probably secondary to cerebral effects of an elevated pH and hypocarbia. 7 Several of our patients exhibited liver disease with jaundice, while some had biochemical alterations of liver function only. Innovar would appear to be a safe agent to use in these individuals. Little or no alteration in liver function by Innovar was found by several authors, s,9
SUMMARY
We have described what appears to us a most satisfactory anaesthetic technique for maior surgery. We use it particularly in patients with whom prudence dictated it would be wise to avoid halogenated hydrocarbons, such as (a) intraabdominal procedures where surgical manipulation may result in liver function abnormalities (i.e. biliary tract surgery), (b) for repeat anaesthetics in patients who recently had halogenated hydrocarbon, (c) for patients iaundiced or with altered liver function tests, (d) for patients with a history of unexplained fever or iaundice following a previous anaesthetic, and (e) for patients who may have been exposed to infectious hepatitis.
We feel meticulous attention to detail is most important to keep Innovar dosage low and thus avoid any post-operative respiratory depression. r RESUME Nous avons ddcrit ce qui nous semble une technique anesthdsique tr~s satisfaisante pour la chirurgie majeure. Nous rayons utilis6e surtout chez les malades pour qui la prudence ineitait ~ 6viter les hydroearbures halog6n6s, (a) les interventions abdominales off les manoeuvres ehirurgieales pouvaient produire des troubles de la fonction du foie (e'est-~t-dire la chirurgie des voles biliaires), (b) pour des anesth6sies rdp6t6es ehez des malades qui ont re9u r6eemment des hydroearbures halog6n6s, (e) pour des malades iet6riques ou ayant un trouble des @reuves de la fonction h@atique, (d) pour les malades pr6sentant une histoire de figvre ou d'iet~re inexpliqu6s & la suite d'une anesthdsie ant6rieure, et (e) pour des malades qui ont 6t6 expos6s ~t l'h@atite infectieuse.
Nous erovons qu'il est trbs important de maintenir un faible dosage d'Innovar et ainsi d'4viter toute d@ression respiratoire post-op6ratoire.
